268
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Preparation and characterization of self nano-emulsifying drug delivery system (SNEDDS) for oral delivery of heparin using hydrophobic complexation by cationic polymer of β-cyclodextrin

, &
Pages 1899-1907 | Received 22 Feb 2017, Accepted 05 Jul 2017, Published online: 26 Jul 2017

References

  • Agnelli G, Sonaglia F. Prevention of venous thromboembolism. Thromb Res. 2000;97:49–62.
  • Prasad YR, Minamimoto T, Yoshikawa Y, et al. In situ intestinal absorption studies on low molecular weight heparin in rats using Labrasol as absorption enhancer. Int J Pharm. 2004;271:225–232.
  • Paliwal R, Paliwal SR, Agrawal GP, et al. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: in vitro and in vivo evaluation. Int J Pharm. 2012;422:179–184.
  • Paliwal R, Paliwal SR, Agrawal GP, et al. Recent advances in search of oral heparin therapeutics. Med Res Rev. 2012;32:388–409.
  • Arbit E, Goldberg M, Gomez Orellana I, et al. Oral heparin: status review. Thromb J. 2006;4:6.
  • Ito Y, Kusawake T, Prasad YR, et al. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies. Int J Pharm. 2006;317:114–119.
  • Jaques L. Heparins-anionic polyelectrolyte drugs. Pharmacol Rev. 1979;31:99–166.
  • Ke WT, Lin SY, Ho HO, et al. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs. J Control Release. 2005;102:489–507.
  • Rao SVR, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int J Pharm. 2008;362:2–9.
  • Lee DY, Lee J, Lee S, et al. Liphophilic complexation of heparin based on bile acid for oral delivery. J Control Release. 2007;123:39–45.
  • Nazzal S, Smalyukh I, Lavrentovich O, et al. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm. 2002;235:247–265.
  • Nigade PM, Patil SL, Tiwari SS. Self Emulsifying drug delivery system (SEDDS): a review. Int J Pharm Biol Sci. 2012;2:42–52.
  • Shah P, Bhalodia D, Shelat P. Nanoemulsion: a pharmaceutical review. Syst Rev Pharm. 2010;1:24.
  • Shah R, Zidan A, Funck T, et al. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J Pharm. 2007;341:189–194.
  • Trapani A, Laquintana V, Denora N, et al. Eudragit RS 100 microparticles containing 2-hydroxypropyl-β-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies. Eur J Pharm Sci. 2007;30:64–74.
  • Zhang N, Li J, Jiang W, et al. Effective protection and controlled release of insulin by cationic β-cyclodextrin polymers from alginate/chitosan nanoparticles. Int J Pharm. 2010;393:213–219.
  • Rowsen L, Moses KJD, Sharma CP. Beta cyclodextrin-insulin encapsulated chitosan/alginate matrix: oral delivery system. J Appl Polym Sci. 1999;75:1089–1096.
  • Mansourpour M, Mahjub R, Amini M, et al. Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery. AAPS Pharm Sci Tech. 2015;16:952–961.
  • Mahjub R, Shayesteh TH, Radmehr M, et al. Preparation and optimization of N-trimethyl-O-carboxymethyl chitosan nanoparticles for delivery of low-molecular-weight heparin. Pharm Dev Technol. 2016;21:14–25.
  • Rawat A, Yang T, Hussain A, et al. Complexation of a poly-Larginine with low molecular weight heparin enhances pulmonary absorption of the drug. Pharm Res. 2008;25:936–948.
  • Wold S, Sjostrom M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom Intell Lab Syst. 2001;58:109–130.
  • Shahsavari S, Bagheri G, Mahjub R, et al. Application of artificial neural networks for optimization of preparation of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan. Drug Res. 2014;40:1645–1659.
  • Shahsavari S, Rezaie Shirmard L, Amini M, et al. Application of artificial neural networks in the design and optimization of a nanoparticulate fingolimod delivery system based on biodegradable Poly(3-Hydroxybutyrate-Co-3-Hydroxyvalerate). J Pharm Sci. 2017;106:176–182.
  • Ghosh PK, Majithiya RJ, Umrethia ML, et al. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS Pharm Sci Tech. 2006;7:77.
  • Nepal PR, Han HK, Choi HK. Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10). Eur J Pharm Sci. 2010;39:224–232.
  • Sarciaux J, Acar L, Sado P. Using microemulsion formulations for oral drug delivery of therapeutic peptides. Int J Pharm. 1995;120:127–136.
  • Swenson ES, Curatolo WJ. (C) Means to enhance penetration: (2) Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv Drug Del Rev. 1992;8:39–92.
  • Choi SH, Park TG. Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres. Int J Pharm. 2000;203:193–202.
  • Powers ME, Matsuura J, Brasell J, et al. Enhanced solubility of proteins and peptides in nonpolar solvents through hydrophobic ion pairing. Biopolymers. 1993;33:927–932.
  • Mahjub R, Dorkoosh FA, Rafiee-Tehrani M, et al. Oral self-nanoemulsifying peptide drug delivery systems: impact of lipase on drug release. J Microencapsul. 2015;32:401–407.
  • Zupancic O, Greiβinger JA, Rohrer J, et al. Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration. Eur J Pharm Biopharm. 2016;109:113–121.
  • Zupancic O, Leonaviciute G, Lam HT, et al. Development and in vitro evaluation of an oral SEDDS for desmopressin. Drug Deliv. 2016;23:2074–2083.
  • Shahnaz G, Hartl M, Barthelmes J, et al. Uptake of phenothiazines by the harvested chylomicrons ex vivo model: influence of self-nanoemulsifying formulation design. Eur J Pharm Biopharm. 2011;79:171–180.
  • Leonaviciute G, Adamovic NT, Lam HT, et al. Self-emulsifying drug delivery systems (SEDDS): proof-of-concept how to make them mucoadhesive. Eur J Pharm Biopharm. 2017;112:51–57.
  • Freidl H, Dunnhaupt S, Hintzen F, et al. Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems. J Pharm Sci. 2013;102:4406–4413.
  • Hintzen F, Laffluer F, Sarti F, et al. In vitro and ex vivo evaluation of an intestinal permeation enhancing self microemulsifying drug delivery systems (SMEDDS). J Drug Del Sci Tech. 2013;23:261–267.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.